Ionis Pharmaceuticals | IONS - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Agios Pharmaceuticals USD 1.18B 4.3B 2026-03
Alnylam Pharmaceuticals USD 69.29M 60.05M 2026-03
Arrowhead Research USD 22.5M 811K 2025-12
Astellas Pharma JPY 3.91B 320M 2025-03
BioCryst Pharmaceuticals USD 14.14M 5.53M 2025-12
BioMarin Pharmaceutical USD 14.96M 12.18M 2026-03
Celltrion KRW 19B 1.96B 2025-06
Cspc Pharmaceutical CNY 6.76M 3.43M 2025-12
Deva Holding AS TRY 272.53M 69.04M 2023-09
Divis Laboratories Ltd INR 60M 0 2026-03
Esperion Therapeutics USD 22.64M 585K 2025-12
Exelixis USD 23.4M 3.9M 2023-09
Halozyme Therapeutics USD 5.51M 597K 2026-03
Ionis Pharmaceuticals USD 17M 1000K 2026-03
Kangmei Pharma CNY 1.82M 150K 2025-09
Knight Therapeutics CAD 3.92M 1.56M 2025-12
Laboratorios Farma EUR 699K 666.2K 2025-06
Medical Developments International AUD 18K 3K 2025-06
Moderna USD 11.49B 36B 2026-03
Nektar Therapeutics USD 9.77M 3.75M 2025-12
Neuren Pharmaceuticals AUD 0 0 2024-06
Neurocrine Biosciences USD 1.1M 0 2024-03
Novartis USD 343M 39M 2026-03
Omeros USD 4.05M 5.16M 2024-09
OPKO Health USD 11.11M 352K 2025-12
Organigram Holdings CAD 179K 127K 2025-03
Ovoca Bio EUR 7K 6K 2022-06
Pfizer USD 671M 40M 2026-03
Pharma Mar EUR 117K 1.24M 2025-09
PTC Therapeutics USD 2.87B 2.82B 2026-03
Qiagen NV USD 10.14M 1.92M 2025-12
Regeneron Pharmaceuticals USD 12.9M 700K 2026-03
Roche Holding CHF 304M 7.5M 2025-06
Sarepta Therapeutics USD 20.84M 13.28M 2025-12
Sartorius EUR 49.5M 8.1M 2025-09
Sino Biopharmaceutical CNY 76.87M 114.23M 2024-06
Tilray USD 6.7M 2.73M 2025-06
Ultragenyx Pharmaceutical USD 21M 2M 2026-03
Vertex Pharmaceuticals USD 3.3M 0 2025-12
Zealand Pharma A/S 7.07M 74K 2025-12
Zz Pientze Pharmaceu CNY 46.05M 36.5M 2025-06